Agios To Present at September Investor Conferences
August 30 2021 - 07:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism developing and delivering innovative
treatments for genetically defined diseases, today announced that
the company is scheduled to present at the following September
investor conferences:
- Citi’s 16th Annual
Biopharma Virtual Conference Panel: Sickle Cell,
Beta-Thal, ITP & PKD - Measuring Industry Progress in Benign
Hematology Friday, September 10 at 12:30 p.m. ET
- 2021 Cantor Virtual Global Healthcare
Conference Monday, September 27 at 8:00 a.m. ET
Live webcasts of the presentations can be accessed under “Events
& Presentations” in the Investors section of the company's
website at www.agios.com. Replays of the webcasts will be archived
on the Agios website for at least two weeks following each
presentation.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat genetically
defined diseases through scientific leadership in the field of
cellular metabolism. The company’s most advanced drug candidate is
a first-in-class pyruvate kinase R (PKR) activator, mitapivat, that
is currently being evaluated for the treatment of three distinct
hemolytic anemias. In addition to its active late-stage clinical
pipeline, Agios has multiple novel, investigational therapies in
clinical and preclinical development. For more information, please
visit the company’s website at www.agios.com.
Contacts
Investors: 1AB Steve
Klasssteve@1abmedia.com
Media: Jessi Rennekamp, 857-209-3286Director,
Corporate CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2023 to Mar 2024